About Us

Our Story

Chemistry Unfolding

Founded in 2005 from Dr. P.Y. Reddy’s belief that chemistry is transformative, Sapala Organics began as a trusted partner for Japan’s pharma industry. His vision, alongside Dr. Yogesh Sanghvi’s expertise in nucleic acid chemistry, fueled a journey into new frontiers of medicinal chemistry.

With over a century of combined experience across 18 labs, our team doesn’t just solve problems; we redefine possibilities, molecule by molecule. Our recent partnership with Suven Pharma further deepens our CDMO and medicinal chemistry focus, leading us into the future.

Our guiding question remains: Where next? We’ll follow the chemistry—it lights our path forward.

Ownership

Sapala Organics is now a proud subsidiary of Suven Pharmaceuticals Limited, a Global Pharma CDMO and a specialty chemical innovator. With this acquisition, Suven aims to leverage Sapala’s expertise in the high-growth oligonucleotide and Nucleic Acid building blocks sector, particularly in advanced oligo technologies and complex Amidite and nucleoside building blocks. Sapala’s unique capabilities and proven track record in complex synthesis make it a strategic fit for Suven’s vision of expanding in niche technology platforms. This coming together unlocks manufacturing scale-up and global commercialization capabilities, enhancing Sapala’s growth and elevating its pharmaceutical offerings. 

Vision & Mission

To be recognized as an able, trusted & socially responsible scientific organization.

To build a sustained relationships with business partners by offering high quality professional services through Innovation in Chemical Science & Drug discovery Technologies.

Founder/CEO Message

Roman philosopher Cicero said, ‘As long as there is life, there is hope.’ This truth inspires our commitment to providing hope through next-gen genetic care and small molecule NCE.

Every day, Sapala’s 250+ employees quietly contribute to shaping a future full of possibilities.

As pioneers in nucleic acid chemistry, we bring extensive expertise and a partnership ethos built on trust, making us a reliable CRO & CDMO partner for drug discovery.

We look forward to helping you ride the next wave of genetic therapies.

Founder & CEO

Leadership

Board of Directors

Management

Our management team is a blend of visionary leaders with deep-rooted expertise in chemical development and manufacturing. Like the backbone of a DNA strand, they provide the structure and guidance that shape our strategic vision, ensuring operational excellence at every step. Their decades of experience fuel Sapala’s growth, leading us to break new ground in the chemical industry.

Founder, President & CEO

President – North America
Executive VP – Fin, Admin & HR
Senior VP – R&D

Assoc. VP – Manufacturing

Tadashi Matsuda

Representative Director – Sapala Co. Ltd. (Japan)
AGM – Business Development

AGM – Accounts

Chief Commercial Officer
Suven Pharmaceuticals

R&D Team

Our research and development team forms the core of our innovation engine. Just as nucleic acids are the blueprint of life, their work lays the foundation for Sapala’s leadership in medicinal and nucleic acid chemistry. Constantly pushing the boundaries of what’s possible, they develop cutting-edge solutions that redefine the CDMO landscape and drive our success.

Associate Director
Principal Scientist
Associate Director
Principal Scientist
Senior Scientific Officer

Senior Scientific Officer

Research Scientist
Principal Scientist
Senior Scientific Officer
Principal Scientist
Deputy Director
Principal Scientist
Scientific Officer
Principal Scientist

Quality

At Sapala, every process is governed by industry-grade quality standards. And we hold accreditations like ISO 9001, ISO 27001 and others. As we continue to explore the depths of chemistry, our commitment to adhering to the highest quality standards only intensifies further. 

ISO 27701:2019

ISO 27001:2013

ISO 9001:2015

In-house R&D Unit Certified by DSIR

Drugs Control Administration, Telangana

CSR

At Sapala, we are committed to creating a positive impact beyond business through our comprehensive Corporate Social Responsibility (CSR) and sustainability initiatives. Our focus is on empowering communities and ensuring environmental stewardship.

We actively contribute to education, healthcare, and skill development programs in the regions we operate, driving social progress and sustainable development. In alignment with our sustainability goals, we continuously optimize our operations to reduce our environmental footprint, from energy-efficient practices to responsible waste management.

Sapala Meaning

What’s in a Name?
More Than You Think.

Our name, SAPALA, draws from the power of three revered Indian goddesses—Saraswathi, Parvathi, and Lakshmi—embodying knowledge, strength, and well-being.

Saraswathi fuels our pursuit of knowledge and innovation; Parvathi represents collaborative strength, essential in overcoming scientific challenges; and Lakshmi signifies prosperity and health, guiding us toward sustainable impact.

Together, these ideals form SAPALA’s guiding principle: “Well-Being Through the Power of Knowledge,” driving us to impact lives positively, one discovery at a time.

Trivia

There’s more to Sapala
than what meets the eye.

Did you know we’re more than just nucleic acid chemistry experts? At Sapala, we’ve been quietly shaping the future for close to 20 years—and we bet you’ve felt our impact without even realizing it! 

Did You Know…

  • Sapala’s Founder-CEO Dr. P.Y. Reddy 
    1. was instrumental in carrying out Collaborative Research between Aisin Cosmos R&D Co Ltd (Toyota Group) and IICT (Govt. of India) and EPFL, Switzerland for more than 15 years.
    2. was a key person to introduce DSSC Technology in India.
    3. is credited with 40+ publications in international journals, 30+ Japanese and international patent filings, 40+ lectures in different countries.
  • Sapala was the first Indian CDMO to successfully complete a full-spectrum of nucleic acid project (from R&D to clinical trial) for an international client.
  • Sapala operates 18 state-of-the-art R&D laboratories, enabling innovative research in medicinal and nucleic acid chemistry.
  • Sapala has a scientific team boasting over 100 years of combined experience, driving innovation in medicinal and nucleic acid chemistry.
  • Sapala is amongst the top companies in specialized phosphoramidites such as BNA and DDS compounds such as GalNAc.
  • Sapala collaborates with leading global firms to advance cutting-edge therapies, positioning itself as a key player in the CDMO landscape.
  • Sapala has 20+ PhDs working in the R&D division. 
  • Sapala team has an average publish rate of 200+ publications across leading journals.